Clinical Trials Directory

Trials / Completed

CompletedNCT05722106

Improving Adherence to COVID-19 Prevention Behaviours: Test of Persuasive Messages

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,746 (actual)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this randomized online experiment was to test the effectiveness of using various persuasive appeals (deontological moral frame, empathy, identifiable victim, goal proximity, and reciprocity) at improving intentions to adhere to prevention behaviors. Participants indicated their intentions to follow public health guidelines, saw one of six flyers featuring a persuasive appeal or no appeal, then rated their intentions a second time. Known correlates of attitudes toward public health measures were also measured.

Detailed description

Adherence to non-pharmaceutical interventions (NPIs) for COVID-19, including physical distancing, masking, staying home while sick, and avoiding crowded indoor spaces remain critical for limiting the spread of COVID-19. This study tests the effectiveness of using various persuasive appeals (deontological moral frame, empathy, identifiable victim, goal proximity, and reciprocity) at improving intentions to adhere to prevention behaviors. A randomized online experiment using a representative sample of adult Canadian residents with respect to age, ethnicity, and province of residence was conducted between March 3-6, 2021. Participants indicated their intentions to follow public health guidelines, saw one of six flyers featuring a persuasive appeal or no appeal, then rated their intentions a second time. Known correlates of attitudes toward public health measures were also measured.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPersuasive AppealPersuasive appeals were manipulated using promotional flyers ostensibly distributed by the Public Health Agency of Canada.

Timeline

Start date
2021-03-03
Primary completion
2021-03-06
Completion
2021-03-06
First posted
2023-02-10
Last updated
2023-02-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05722106. Inclusion in this directory is not an endorsement.